Navigation Links
AEterna Zentaris to Present at Upcoming Canaccord Adams 29th Annual Global Growth Conference
Date:8/6/2009

QUEBEC CITY, Aug. 6 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its President and CEO, Juergen Engel, Ph.D., will present a corporate overview at the upcoming Canaccord Adams 29th Annual Global Growth Conference on Wednesday, August 12, 2009 at 2:00 p.m. (eastern time) at the Intercontinental Hotel in Boston.

A live webcast of the presentation will be available on AEterna Zentaris' website at www.aezsinc.com in the Investors section. A replay will also be available for a period of 30 days on the Company's website.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.


'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , , Primary efficacy endpoint has been me...t endometrial cancer, , QUEBEC CITY, Nov. 24 ...SDAQ: AEZS ; TSX: AEZ) (the "Company"), a global ...rapy and oncology, today announced positive effica...otoxic peptide conjugate, AEZS-108 (formerly AN-15...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-FirstC... global specialty biopharmaceutical company, today...pean Medicines Agency for,velaglucerase alfa, the ...t,for the treatment of Type 1 Gaucher disease. Thi...rase alfa that has been submitted, with previous,s...
(Date:11/24/2009)... , REDWOOD CITY, Calif., Nov. 24 /PRNewswire... ) today announced that Randy Scott, Genomic Healt...nnual Piper Jaffray Health Care Conference in New ...m. ET. ,, To access the live and subsequently ...vestor Relations section of Genomic Health,s websi...
(Date:11/24/2009)... Program Connects Customers wi...es Collected with DNA Genotek Products , ...09 -- DNA Genotek , a leading provider of product...and preparation, today announced its new global pa...ncements for DNA Genotek,s partner community and i...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
... DuPont Applied BioSciences has turned to MB...ing the commercial viability of an important bio-b...n bridging the gap between research and commercial...sed technologies. MBI’s unique “Collab...ddresses technological uncertainties, which impede...
...ec. 2 GeneGo, Inc., the leading systems biology t...ome a certified GeneGo Center of Excellence. Burnh...o GeneGo,s MetaCore data analysis suite, training ...world-class biomedical research facility running m... departments, including research in cancer, stem c...
...ec. 2 Intradigm Corporation, a leading,developer ...apeutics, today,announced the issuance of United S...ositions for Controlling Efficacy of RNA Silencing...al research of Philip Zamore, Ph.D., the,Gretchen ...sor of Biochemistry,& Molecular Pharmacology a...
Other Biology Technology: DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product 2The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 2Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 3
(Date:11/26/2009)...RSA (methicillin-resistant Staphylococcus Aureus ...ihilation as low-temperature plasma prototype devi... and unfailing bactericidal cocktails. , Two pro...ent disinfection of healthy skin (e.g. hands and f... can pose a lethal threat; and another to shoot ba...
(Date:11/25/2009)...thens, Ga. Bacteria don,t have easy lives. In add... bugs, they have natural enemies called bacterioph... every two days. , Still, bacteria and another ...overed in extreme environments such as deep-sea vo... because they have a built-in defense system that ...
(Date:11/25/2009)...ADISON, WI, NOVEMBER 25, 2009 Soil is the linchpi... and hydrosphere meet. Despite that, many students...but nothing more. Soil science educators are chall...blic recognize the critical importance of soil in ...oil science and earth science teachers at Universi...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3It's not just dirt! 2Now butterflies are also being counted in China Australia and Israel 9574 1Now butterflies are also being counted in China Australia and Israel 9574 2Now butterflies are also being counted in China Australia and Israel 9574 3Now butterflies are also being counted in China Australia and Israel 9574 4International Robotic Surgery Forum Launches In Chicago 54545 1International Robotic Surgery Forum Launches In Chicago 54545 2International Robotic Surgery Forum Launches In Chicago 54545 3Biopelle Inc Acquires PRESCRIBEDsolutions 5BCUSTOMIZED SKINCARE 5D 28R 29 54541 1Biopelle Inc Acquires PRESCRIBEDsolutions 5BCUSTOMIZED SKINCARE 5D 28R 29 54541 2Biopelle Inc Acquires PRESCRIBEDsolutions 5BCUSTOMIZED SKINCARE 5D 28R 29 54541 3
...y of Pennsylvania researchers have uncovered an im...ses cooperating proteins found on its outer coat t...Further, the studys authors say, they have demonst...n interactions using biomolecular complementation....the National Academy of Sciences, provide a better...
...ong been a staple for people planning their day. N...re working to broaden daily forecasts to include p... reality in some parts of the world. , Some scien...e, global forecasts of air pollution near the grou...ears away. Such a system could prove useful in eff...
...tural climate variations, which tend to involve lo...ve a larger effect on hurricane activity than the ...in this week,s Nature suggests. , In the debate o... is generally assumed that warmer oceans provide a...ent and intensification. However, several other fa...
Other Biology News:Penn researchers shine the light of venus to learn how the herpes virus invades cells 2Air quality forecasts see future in space 2Air quality forecasts see future in space 3Climate's remote control on hurricanes 2
...via cardiac puncture from 3 to 4 week old rabbits ...uged and frozen at -70C. The complement is thawed,...tored at -70C. DIRECT SALES FROM PEL-FREEZ BIOLOGI..., YOU CAN NOW BUY DIRECTLY FROM THE SOURCE! FORMER...
Dacron mesh button tether single channel infusion of rats, sterile from Instech Solomon
GIBCO Donor Calf Serum from Invitrogen
Genes VI from Promega
Biology Products: